StellaLife Revenue and Competitors

Miami, FL USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • StellaLifeÂ's estimated annual revenue is currently $3.7M per year.(i)
  • StellaLifeÂ's estimated revenue per employee is $155,000

Employee Data

  • StellaLife has 24 Employees.(i)
  • StellaLife grew their employee count by 4% last year.

StellaLifeÂ's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.3M995%N/AN/A
#2
$1.1M7-30%N/AN/A
#3
$3.7M244%N/AN/A
#4
$4.3M28-3%N/AN/A
#5
$2.5M16N/AN/AN/A
#6
$0.8M50%N/AN/A
#7
$1.1M70%N/AN/A
#8
$2.5M167%N/AN/A
#9
$1.4M9-25%N/AN/A
#10
$0.6M40%N/AN/A
Add Company

What Is StellaLifeÂ?

StellaLife® is a biotech company on a mission to improve people’s lives by accelerating healing, relieving pain, and significantly reducing, or in some cases eliminating, the need for opioids. Our introductory all-natural product line is the VEGA® Oral Care medicine. This revolutionary new technology is formulated to improve dental postsurgical recovery and optimize oral-systemic health. We believe that better healing can be done more naturally. Less pain. Less medication. More peace of mind. StellaLife® makes oral health and pain management solutions that improve dental patients’ experience. We believe that better oral health comes from better ingredients and better formulations. Our innovative approach is an extremely effective alternative to traditional products. VEGA® Oral Care solutions are clinically proven to reduce pain, bruising and swelling, with a faster healing time. In addition, our solutions deliver exceptional long-term oral health. All done in a more natural way. *Individual results may vary. Visit StellaLife.com for full disclaimer*

keywords:N/A

N/A

Total Funding

24

Number of Employees

$3.7M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.4M2723%N/A
#2
$4.1M280%N/A
#3
$4.9M288%N/A
#4
N/A30-58%N/A
#5
$8.1M317%N/A